EVALUATION OF OUTCOME AND CHIMERIC STATUS FOLLOWING HLA IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA USING IN-VIVO CAMPATH-1G

Similar Items

• Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
  by: Hamblin, M, et al.
  Published: (1996)
• Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
  by: Gupta, V, et al.
  Published: (2004)
• Long-term outcome after marrow transplantation from HLA-identical sibling donors for acquired aplastic anaemia using cyclophosphamide and in-vivo anti-CD52 monoclonal antibodies
  by: Gupta, V, et al.
  Published: (2005)
• RESULTS OF T-CELL DEPLETION WITH CAMPATH-1 IN BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC GRANULOCYTIC-LEUKEMIA (CGL)
  by: Apperley, J, et al.
  Published: (1985)
• Favourable impact on acute and chronic graft-versus-host disease with cyclophosphamide and in-vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anaemia.
  by: Gupta, V, et al.
  Published: (2004)